Ultra-low-field MRI for Accessible Healthcare

Making MRI accessible to everyone, everywhere. We engineer the future of medical imaging at field strengths 100× lower than conventional scanners — combining hardware innovation, AI-driven reconstruction, and novel pulse sequences to deliver diagnostic-quality imaging without expensive infrastructure.

Mission

Democratising MRI for Global Healthcare

Over 90% of the world's MRI scanners are concentrated in high-income countries, leaving billions without access to this critical diagnostic tool. Our mission is to fundamentally reimagine MRI technology — developing ultra-low-field ( < 0.1 T) systems that are low-cost, portable, shielding-free, and acoustically quiet. By integrating advances in electromagnetic engineering, deep learning, and novel MR physics, we aim to close the global healthcare imaging gap.

Goals

Engineering and AI-Driven Reconstruction at Ultra-low-field

01

Ultra-low-field MRI, Physics and Engineering

Develop fundamental MRI physics and hardware engineering at ultra-low magnetic field strengths (0.05 Tesla). Our work focuses on optimizing magnet design, gradient coil engineering, and radiofrequency coil development to achieve high-quality imaging despite the inherent signal-to-noise ratio challenges of ultra-low-field operation.

02

Fast-MRI and Computing-Powered Deep Learning Image Formation

Harness artificial intelligence and advanced computational methods to overcome the fundamental limitations of ultra-low-field MRI acquisition. We develop deep learning algorithms for 3D super-resolution reconstruction and unsupervised domain adaptation that transform low-quality 0.05T acquisitions into clinically useful images.

03

Active Sensing EMI Elimination for Shielding-Free MRI

Eliminate the need for expensive radiofrequency shielding cages through active electromagnetic interference (EMI) sensing and deep learning-based cancellation. We employ active sensing coils and neural network-based signal prediction to detect and nullify environmental EMI in real-time, enabling MRI operation in unshielded clinical environments.

04

Clinical Deployment: Achieving Low-Cost Healthcare

Translate ultra-low-field MRI technology into practical clinical systems for real-world healthcare settings. We focus on creating compact, mobile, and user-friendly systems that operate from standard power outlets, targeting point-of-care imaging at the bedside and in community clinics to democratize access to MRI globally.

Findings & Current Achievements

From Vision to Reality

Science (2024)

Whole-Body Magnetic Resonance Imaging at 0.05 Tesla

Demonstrated the first whole-body MRI at 0.05 Tesla, proving that ultra-low-field systems can produce satisfactory images for anatomical and functional imaging across all major body regions — brain, spine, abdomen, extremities — opening a new paradigm for accessible healthcare imaging.

Magnetic Resonance in Medicine (2023, 2024)

EMI Elimination & Deep Learning Reconstruction

Developed multiple approaches for robust EMI elimination through active sensing, deep learning direct MR signal prediction, and null orthogonal projection.

Science Advances (2023)

Deep Learning Enabled Fast 3D Brain MRI at 0.055 Tesla

Enabled fast 3D brain MRI at 0.055T through deep learning, achieving clinically useful image quality in dramatically reduced scan times. Highlighted by Nature commentary as a breakthrough in accessible neuroimaging.

Nature Communications (2021)

A Low-Cost and Shielding-Free Ultra-Low-Field Brain MRI Scanner

Built a low-cost, shielding-free ultra-low-field brain MRI scanner using a permanent 0.055T magnet and deep learning for EMI cancellation. Featured in Nature Briefing and Scientific American. This work established the feasibility of MRI without expensive RF shielding infrastructure.

Future

The Next Frontier

We envision a world where MRI is as accessible as Ultrasound. Our roadmap includes developing next-generation ultra-low-field systems with multi-channel EMI cancellation, expanding clinical protocols for neurological, abdominal and musculoskeletal imaging with advanced contrast mechanisms (magnetization transfer, angiography, diffusion), and establishing partnerships to deploy these systems globally. We are also pursuing AI-driven automated analysis and diagnosis pipelines that can operate directly on low-field images, enabling point-of-care decision support.

Next: Research Area 02 Optogenetic fMRI for Brain-wide Circuit Dissection